U.S. Other Source Research Antibody Market Size & Outlook
U.S. other source research antibody market, 2018-2030 (US$M)
Related Markets
U.S. other source research antibody market highlights
- The U.S. other source research antibody market generated a revenue of USD 47.1 million in 2023 and is expected to reach USD 59.4 million by 2030.
- The U.S. market is expected to grow at a CAGR of 3.4% from 2024 to 2030.
- In terms of segment, oncology was the largest revenue generating application in 2023.
- Infectious Diseases is the most lucrative application segment registering the fastest growth during the forecast period.
Other source research antibody market data book summary
| Market revenue in 2023 | USD 47.1 million |
| Market revenue in 2030 | USD 59.4 million |
| Growth rate | 3.4% (CAGR from 2023 to 2030) |
| Largest segment | Oncology |
| Fastest growing segment | Infectious Diseases |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Infectious Diseases, Immunology, Oncology, Stem Cells, Neurobiology |
Other key industry trends
- In terms of revenue, U.S. accounted for 35.5% of the global other source research antibody market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. other source research antibody market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 12.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Other Source Research Antibody Market Scope
Other Source Research Antibody Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. other source research antibody market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to other source research antibody market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 34.18% in 2023. Horizon Databook has segmented the U.S. other source research antibody market based on infectious diseases, immunology, oncology, stem cells, neurobiology covering the revenue growth of each sub-segment from 2018 to 2030.
- U.S. Other Source Research Antibody Application Outlook (Revenue, USD Million, 2018-2030)
- Infectious Diseases
- Immunology
- Oncology
- Stem Cells
- Neurobiology
- Others
Reasons to subscribe to U.S. other source research antibody market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. other source research antibody market databook
-
Our clientele includes a mix of other source research antibody market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. other source research antibody market , including forecasts for subscribers. This country databook contains high-level insights into U.S. other source research antibody market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. other source research antibody market size, by application, 2018-2030 (US$M)
U.S. Other Source Research Antibody Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
